Link Pharma Chem Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	-10.27	-13.63	6.54	18.82	10.85
Depreciation & Amortization	9.43	10.34	9.23	9.28	8.74
Loss (Gain) From Sale of Assets	-	-0.79	-	-1.18	1.64
Loss (Gain) From Sale of Investments	-1.25	-4.94	2.61	-2.19	-
Provision & Write-off of Bad Debts	0.23	0.56	4.15	0.35	-
Other Operating Activities	3.46	-0.73	4.74	3.98	5.42
Change in Accounts Receivable	1.11	-15.77	13.2	1.52	-5.57
Change in Inventory	4.72	60.42	-74.93	-22.61	-8.65
Change in Accounts Payable	20.05	-49.5	6.46	-17.12	48.24
Change in Other Net Operating Assets	-0.62	13.77	10.94	-3.43	-12.21
Operating Cash Flow	26.86	-0.28	-17.07	-12.59	48.45
Operating Cash Flow Growth	-	-	-	-	63.98%
Capital Expenditures	-2.57	-9.5	-8.93	-11.56	-18.06
Sale of Property, Plant & Equipment	-	1.2	-	4.11	1.03
Investment in Securities	17.25	11.54	6.7	-43.24	-4.53
Other Investing Activities	0.62	0.81	1.48	1.01	-0.07
Investing Cash Flow	15.29	4.05	-0.75	-49.67	-21.63
Short-Term Debt Issued	-	20.29	32.05	25.84	-
Long-Term Debt Issued	-	-	5.3	10	14.98
Total Debt Issued	-	20.29	37.35	35.84	14.98
Short-Term Debt Repaid	-26.95	-	-	-	-
Long-Term Debt Repaid	-7.44	-15.64	-13.66	-8.61	-13.88
Total Debt Repaid	-34.39	-15.64	-13.66	-8.61	-13.88
Net Debt Issued (Repaid)	-34.39	4.65	23.69	27.24	1.1
Other Financing Activities	-7.76	-8.72	-7.61	-4.51	-4.4
Financing Cash Flow	-42.15	-4.07	16.08	22.72	-3.3
Miscellaneous Cash Flow Adjustments	-	0	-	-	-
Net Cash Flow	0	-0.3	-1.74	-39.54	23.52
Free Cash Flow	24.29	-9.78	-26	-24.15	30.39
Free Cash Flow Growth	-	-	-	-	144.76%
Free Cash Flow Margin	9.55%	-3.27%	-6.71%	-4.51%	8.73%
Free Cash Flow Per Share	5.47	-2.20	-5.86	-5.44	6.84
Cash Interest Paid	7.76	8.72	7.61	4.07	4.18
Cash Income Tax Paid	-0.34	3.7	4.06	6.75	4.76
Levered Free Cash Flow	19.05	-4.16	-28.64	-35.68	26.59
Unlevered Free Cash Flow	23.9	1.29	-23.89	-32.86	29.35
Change in Working Capital	25.26	8.91	-44.33	-41.64	21.81

Source: S&P Global Market Intelligence. Standard template. Financial Sources.